MEDIPOST Statistics

Total Valuation

MEDIPOST has a market cap or net worth of KRW 298.71 billion. The enterprise value is 276.07 billion.

Market Cap	298.71B
Enterprise Value	276.07B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDIPOST has 34.10 million shares outstanding. The number of shares has increased by 34.85% in one year.

Current Share Class	n/a
Shares Outstanding	34.10M
Shares Change (YoY)	+34.85%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	0.93%
Float	20.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.23
PB Ratio	1.19
P/TBV Ratio	1.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.42
EV / Sales	3.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.91

Financial Position

The company has a current ratio of 5.79, with a Debt / Equity ratio of 0.04.

Current Ratio	5.79
Quick Ratio	4.55
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-97.24

Financial Efficiency

Return on equity (ROE) is -19.06% and return on invested capital (ROIC) is -8.82%.

Return on Equity (ROE)	-19.06%
Return on Assets (ROA)	-7.03%
Return on Invested Capital (ROIC)	-8.82%
Return on Capital Employed (ROCE)	-12.42%
Revenue Per Employee	229.41M
Profits Per Employee	-203.00M
Employee Count	308
Asset Turnover	0.16
Inventory Turnover	1.73

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +24.22% in the last 52 weeks. The beta is 0.31, so MEDIPOST's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+24.22%
50-Day Moving Average	9,674.60
200-Day Moving Average	8,045.05
Relative Strength Index (RSI)	44.24
Average Volume (20 Days)	152,769

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDIPOST had revenue of KRW 70.66 billion and -62.52 billion in losses. Loss per share was -1,834.00.

Revenue	70.66B
Gross Profit	44.14B
Operating Income	-48.55B
Pretax Income	-62.93B
Net Income	-62.52B
EBITDA	-42.53B
EBIT	-48.55B
Loss Per Share	-1,834.00

Full Income Statement

Balance Sheet

The company has 93.20 billion in cash and 11.15 billion in debt, giving a net cash position of 82.05 billion or 2,406.17 per share.

Cash & Cash Equivalents	93.20B
Total Debt	11.15B
Net Cash	82.05B
Net Cash Per Share	2,406.17
Equity (Book Value)	310.72B
Book Value Per Share	7,370.07
Working Capital	111.91B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.27 billion and capital expenditures -2.67 billion, giving a free cash flow of -39.93 billion.

Operating Cash Flow	-37.27B
Capital Expenditures	-2.67B
Free Cash Flow	-39.93B
FCF Per Share	-1,171.08

Full Cash Flow Statement

Margins

Gross margin is 62.47%, with operating and profit margins of -68.72% and -88.49%.

Gross Margin	62.47%
Operating Margin	-68.72%
Pretax Margin	-89.07%
Profit Margin	-88.49%
EBITDA Margin	-60.19%
EBIT Margin	-68.72%
FCF Margin	n/a

Dividends & Yields

MEDIPOST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.85%
Shareholder Yield	-34.85%
Earnings Yield	-20.93%
FCF Yield	-13.37%

Stock Splits

The last stock split was on March 29, 2019. It was a forward split with a ratio of 2.

Last Split Date	Mar 29, 2019
Split Type	Forward
Split Ratio	2

Scores

MEDIPOST has an Altman Z-Score of 1.21. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.21
Piotroski F-Score	n/a